Category Archives: Pharmaceuticals & Healthcare

United States Insulin Pump Market is likely to reach USD 4 Billion by the year end of 2022.

insulin-pumpMarket growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pumps is hampering the growth of this market.

Request for Sample Market Report @

The research report titled “United States Insulin Pump Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” examines the market, competitive landscape and trends of the United States Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users. Market outlook in value terms for the forecasted period for Insulin Pump Market has been detailed in the report. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market.

The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation and Tandem Diabetes Care. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• United States Insulin Pump Users and Market Analysis (2011 – 2022)
• United States Insulin Pump Preferred Brand – By Product
• United States Insulin Pump Market: Reimbursement & Regulation System
• United States Insulin Pump Market – Major Deal Types

Key Companies Covered in the Report are as follows:

• Insulet Corporation
• Medtronic
• Roche
• Animas Corporation


1. Executive Summary 

2. United States Diabetes Population (2011 – 2022): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes

3. United States Insulin Pump Market Analysis (2011– 2022)
3.1 Insulin Pump Users
3.1.1 Type 1 Diabetes Insulin Pump Users
3.1.2 Type 2 Diabetes Insulin Pump Users
3.2 Insulin Pump Market

4. Key Drivers and Inhibitors of the United States Insulin Pump Market
4.1 Market Drivers
4.2 Inhibitors

5. United States Insulin Pump Preferred Brand – By Product
5.1 Pediatric
5.2 Adult

Related Market Research Reports

United States X-Ray Safety Glasses Market Report 2017

United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Facility & Forecast

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Contract Research Organization Deals Hit Almost $10 Billion

Contract Research Organization Market – Global Deals and Operational Strategies

The total number of deals in the global Contract Research Organization (CRO) market reached 700 between January 2010 and April 2015, achieving an overall value of $33 billion. 2015 has already contributed the most to the overall deals value during this period, with $9.86 billion achieved between January and April this year alone, representing an almost fourfold increase from the $2.5 billion reached in 2014. This impressive growth was significantly bolstered by Laboratory Corporation of America’s (LabCorp) record $6.1 billion acquisition of Covance in February 2015, enabling LabCorp to strengthen its laboratory and CRO service offerings. In its bid to acquire Covance, the company also issued debt offerings of $2.9 billion.

Contract Research Organization Market: Global Deals and Operational Strategies report discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more than forty public and privately held CROs.

The scope of the report includes:

• Overview of key reasons behind outsourcing, outsourcing service models

• Examples of operational strategies

• Global deals analysis by type and value

• Major acquisitions and partnerships

• Regional analysis of North America, Europe, Asia-Pacific and emerging markets

• SWOT analysis and profiles of key players

Get a company benchmark heatmap analyses for over thirty key players listing their operational strategies.

Publisher : CBR Pharma Insights | Report Available with

PharmaSphere: Emerging Biotechnologies – Stem Cell Therapy

PharmaSphere: Emerging Biotechnologies – Stem Cell Therapy”, provides strategic analysis of the global stem cells industry. It discusses key development trends, regulatory requirements in various markets, recent deals activity and industry dynamic trends, as well as describes the operations strategy of these companies. Furthermore, it includes a geographical segmentation of various markets including the EU and US, as well as emerging markets such as China, India, SouthKorea, and Israel-providing in-depth analysis of these markets regulatory framework, key domestic players and their stem cell pipelines, and strategic outlook.

What else will you gain from this report?

  • Stem Cell Market Dynamics: Key drivers and trends shaping the market, including manufacturing, emerging markets, and development pipeline
  • Financial Performance Insight: Use of 22 key financial metrics to provide insight over stem cell company performance
  • Pipeline Analysis: Detailed information on ten leading stem cell therapies; trend analysis of clinical trial studies and investigators covering over 1000 related trials
  • Deal strategies: Exhaustive discussion on the strategic implications and synergies of deals including, M&A, collaboration as well as capital raisings such as equity offerings, private equity and venture financing activities
  • Regulatory Implications: Guidelines for stem cell usage for developing therapies in seven major markets including US, Europe, Japan, South Korea, Israel, China and India
  • Company Analysis: Competitive landscape covering 40 companies on full pipeline, financials and key overview information

link for more information :

2015 Strategies in the Italian Hematology and Flow Cytometry Markets

This comprehensive report contains 250 pages, 32 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in Italian hematology and flow cytometry markets during the next five years.

The report explores business and technological trends in the Italian hematology and flow cytometry markets; provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.

For full report click here :

%d bloggers like this: